API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2024/02/29/2837813/0/en/ASLAN-Pharmaceuticals-Receives-Favorable-Opinion-From-the-European-Patent-Office-on-Composition-of-Matter-Patent-Application-for-Farudodstat.html
https://www.globenewswire.com/news-release/2023/04/24/2652547/0/en/ASLAN-Pharmaceuticals-Announces-Four-Abstracts-on-Eblasakimab-and-Farudodstat-Including-Two-Late-Breakers-to-be-Presented-at-the-1st-International-Societies-for-Investigative-Derma.html
https://www.globenewswire.com/news-release/2023/03/08/2622898/0/en/ASLAN-Pharmaceuticals-to-Host-Virtual-Research-and-Development-Day-on-Novel-DHODH-Inhibitor-Farudodstat-for-Alopecia-Areata.html